Preclinical Evaluation of a Fluorine-18 Labeled Probe for the Detection of the Expression of PSMA Level in Cancer

[Image: see text] Prostate-specific membrane antigen (PSMA) is a prospect biomarker for the treatment of prostate cancer. Meanwhile, positron emission tomography (PET) is being developed as a significant imaging modality in cancer diagnosis. A new PET probe Glu-ureido-Lys-naphthylalanine-tranexamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yirui, Gao, Dingyao, Chen, Yinfei, Zhang, Yu, Chen, Liping, Mao, Yong, Yu, Chunjing, Qiu, Ling, Lin, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015112/
https://www.ncbi.nlm.nih.gov/pubmed/33817487
http://dx.doi.org/10.1021/acsomega.0c06353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015112/
https://www.ncbi.nlm.nih.gov/pubmed/33817487
http://dx.doi.org/10.1021/acsomega.0c06353

Ejemplares similares